Catalyst Capital Advisors’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.03K	Sell	100 -16,225	-99%	-$607K	﹤0.01%	367
2025 Q4	$568K	Sell	16,325 -800	-5%	-$62.8K	0.01%	172
2025 Q3	$1.42M	Sell	17,125 -975	-5%	-$70.6K	0.03%	131
2025 Q2	$1.33M	Sell	18,100 -1,100	-6%	-$79.8K	0.03%	136
2025 Q1	$2.19M	Buy	+19,200	New	+$1.17M	0.04%	108
2020 Q3	–	Sell	-160	Closed	-$3K	–	291
2020 Q2	$3K	Hold	160	–	–	﹤0.01%	268
2020 Q1	$2K	Sell	160 -640	-80%	-$7.92K	﹤0.01%	223
2019 Q4	$10K	Hold	800	–	–	﹤0.01%	289
2019 Q3	$11K	Hold	800	–	–	﹤0.01%	336
2019 Q2	$9K	Sell	800 -14,900	-95%	-$166K	﹤0.01%	324
2019 Q1	$184K	Sell	15,700 -68,200	-81%	-$847K	0.01%	201
2018 Q4	$1.12M	Buy	+83,900	New	+$1.11M	0.04%	143
2018 Q2	–	Sell	-5,400	Closed	-$89K	–	502
2018 Q1	$89K	Sell	5,400 -62,500	-92%	-$1.16M	﹤0.01%	275
2017 Q4	$1.23M	Sell	67,900 -4,250	-6%	-$77K	0.05%	155
2017 Q3	$1.39M	Buy	72,150 +9,150	+15%	+$136K	0.06%	147
2017 Q2	$743K	Buy	+63,000	New	+$685K	0.03%	200
2014 Q4	–	Sell	-540,000	Closed	-$1.45M	–	506
2014 Q3	$1.45M	Hold	540,000	–	–	0.19%	117
2014 Q2	$1.51M	Buy	+540,000	New	+$1.59M	0.25%	115